Effective treatments, like GLP-1 drugs, are rarely risk-free
Abbasinejad, MD , and her team are excited to offer this new oral option as part of our comprehensive Medical Weight Loss & Wellness Program
AstraZenecas GLP-1 pill, elecoglipron, which in phase II trials showed clinically meaningful weight loss of up to 10.5% at 26 weeks and 11.8% at 36 weeks in the highest-dose groups of adults without diabetes 21
High-throughput optical sensing of nucleic acids in a nanopore array
NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer
Frias JP, Bonora E, Ruiz LN et al (2021) Efficacy and safety of dulaglutide 3.0 mg and 4.5 mg versus dulaglutide 1.5 mg in metformin-treated patients with type 2 diabetes in a randomized controlled trial (AWARD-11)